Cargando…
Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells
The success of adoptive T-cell therapies for the treatment of cancer patients depends on transferred T-lymphocytes finding and infiltrating cancerous tissues. For intravenously transferred T-cells, this means leaving the bloodstream (extravasation) from tumour blood vessels. In inflamed tissues, a k...
Autores principales: | Ager, Ann, Watson, H. Angharad, Wehenkel, Sophie C., Mohammed, Rebar N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264496/ https://www.ncbi.nlm.nih.gov/pubmed/27068943 http://dx.doi.org/10.1042/BST20150254 |
Ejemplares similares
-
SHP-1: the next checkpoint target for cancer immunotherapy?
por: Watson, H. Angharad, et al.
Publicado: (2016) -
Functional impact of splice isoform diversity in individual cells
por: Yap, Karen, et al.
Publicado: (2016) -
Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism
por: Chartoumpekis, Dionysios V., et al.
Publicado: (2015) -
Construction of membrane-bound artificial cells using microfluidics: a new frontier in bottom-up synthetic biology
por: Elani, Yuval
Publicado: (2016) -
Molecular sampling of the allosteric binding pocket of the TSH receptor provides discriminative pharmacophores for antagonist and agonists
por: Hoyer, Inna, et al.
Publicado: (2013)